CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | McCulloch Kevin See Remarks | Sale 10b5-1 | −90,000 | $8.03 | $723K | 1,691,126 |
| 2026-07-01 | KREHER NERISSA Director | Grant or award | +33,582 | 33,582 | ||
| 2026-07-01 | KREHER NERISSA Director | Grant or award · Stock Option (Right to Buy) | +37,910 | $8.00 | $303K | 37,910 |
| 2026-07-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.03 | $134K | 1,161,128 |
| 2026-06-04 | Brady James Aloysius Director | Grant or award | +24,193 | 113,359 | ||
| 2026-06-04 | Brady James Aloysius Director | Grant or award · Stock Option (Right to Buy) | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-04 | Kong Garheng Director | Grant or award | +24,193 | 238,337 | ||
| 2026-06-04 | Kong Garheng Director | Grant or award · Stock Option (Right to Buy) | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-04 | PERSKY MARLA Director | Grant or award 10b5-1 | +24,193 | 150,693 | ||
| 2026-06-04 | PERSKY MARLA Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-04 | HALKUFF DAWN Director | Sale 10b5-1 | −20,000 | $6.09 | $122K | 95,000 |
| 2026-06-04 | HALKUFF DAWN Director | Grant or award 10b5-1 | +24,193 | 119,193 | ||
| 2026-06-04 | HALKUFF DAWN Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Sale 10b5-1 | −16,000 | $6.09 | $98K | 126,500 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award 10b5-1 | +24,193 | 150,693 | ||
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-04 | JOHNSON JOHN Director | Sale 10b5-1 | −15,000 | $6.09 | $91K | 683,083 |
| 2026-06-04 | JOHNSON JOHN Director | Grant or award 10b5-1 | +24,193 | 707,276 | ||
| 2026-06-04 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +32,996 | $6.15 | $203K | 32,996 |
| 2026-06-03 | PERSKY MARLA Director | Sale 10b5-1 | −15,500 | $5.90 | $91K | 126,500 |
Page 2 of 10 · 200 trades